Acute-on-chronic liver failure (ACLF) is a multifaceted condition with poor treatment options
and high short-term mortality. ACLF can develop in patients with or without liver cirrhosis …

Alcohol use disorder is the predominant cause of chronic liver disease globally. The
standard of care for the treatment of alcoholic hepatitis, corticosteroids, has been shown to …

Objective To investigate whether the Notch–Hif-1α signaling pathway is involved in liver
regeneration. Methods Rats were divided into two groups and treated with daily …

Bone marrow–derived mesenchymal stem cells (BM-MSCs) represent an interesting
alternative to liver or hepatocyte transplantation to treat liver injuries. Many studies have …

Stem cells therapy could improve survival in patients with liver failure. Studies on stem cell
therapy and related growth factors in decompensated cirrhosis has been on the forefront but …

In this study, we investigated the affect and the role of growth factors on liver damage. 110
Sprague–Dawley rats were divided into 11 groups: a sham group, a control group, HGF …

This study investigated the efficacy and feasibility of inducing the differentiation of bone
marrow-derived mesenchymal stem cells (BMSCs) into hepatocyte-like cells in vitro using …

ABSTRACT Background & Aims: Acute-on-chronic liver failure (ACLF) is characterized by a
rapid progression to multiple organ failure and is associated with a very high mortality rate of …

We read with interest, the study by Verma et al.(1), on the utility of granulocyte colony-
stimulating factor (GCSF) and growth hormone (GH)(Group A) or GCSF alone (Group B) …

Aims: This study aimed to investigate the impact of perioperative cytokines, clinical variables
and scoring systems on the short-term outcomes of liver transplantation (LT) in hepatitis B …